Finally, to confirm whether Rac1 is regulated by the Cobll1/PACSIN2/SH3BP1 pathway during CML progression, we examined the activity of Rac1 in samples from patients at the BC phase. This evidence concerns the gene SH3BP1 and chronic myelogenous leukemia, BCR-ABL1 positive.